Page last updated: 2024-10-31

metyrapone and Weight Gain

metyrapone has been researched along with Weight Gain in 2 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Weight Gain: Increase in BODY WEIGHT over existing weight.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rehan, VK1
Li, Y1
Corral, J1
Saraswat, A1
Husain, S1
Dhar, A1
Sakurai, R1
Khorram, O1
Torday, JS1
Murphy, MO1
Herald, JB1
Wills, CT1
Unfried, SG1
Cohn, DM1
Loria, AS1

Other Studies

2 other studies available for metyrapone and Weight Gain

ArticleYear
Metyrapone blocks maternal food restriction-induced changes in female rat offspring lung development.
    Reproductive sciences (Thousand Oaks, Calif.), 2014, Volume: 21, Issue:4

    Topics: Age Factors; Animal Nutritional Physiological Phenomena; Animals; Caloric Restriction; Female; Gesta

2014
Postnatal treatment with metyrapone attenuates the effects of diet-induced obesity in female rats exposed to early-life stress.
    American journal of physiology. Endocrinology and metabolism, 2017, 02-01, Volume: 312, Issue:2

    Topics: Animals; Animals, Newborn; Diet, High-Fat; Female; Male; Maternal Deprivation; Metyrapone; Obesity;

2017